Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Aug 15;115(5):475-7.
doi: 10.1161/CIRCRESAHA.114.304589.

Ceramide signaling in the coronary microcirculation: a double-edged sword?

Affiliations
Editorial

Ceramide signaling in the coronary microcirculation: a double-edged sword?

Brian R Weil et al. Circ Res. .
No abstract available

Keywords: Editorials; ceramides; microcirculation.

PubMed Disclaimer

Figures

Figure
Figure. Schematic representation of potential ceramide-mediated structural and functional effects on the coronary microcirculation
In healthy subjects (A), an increase in flow through a coronary arteriole elicits flow-induced dilation mediated by endothelium-derived nitric oxide. Ceramide accumulation occurs with the development of coronary artery disease (B), promoting a switch in the mediator of flow-induced dilation from nitric oxide to hydrogen peroxide. In addition, ceramide signaling elicits proliferation of vascular smooth muscle cells, contributing to arteriolar structural remodeling characterized by increased wall thickness and reduced lumen diameter. Although the compensatory up-regulation of hydrogen peroxide-mediated vasodilation preserves the relative magnitude of flow-induced dilation, structural changes limit the absolute dilatory capacity of the vessel, resulting in an increased minimum coronary vascular resistance that limits coronary flow reserve.

Comment on

References

    1. Canty JM., Jr . Coronary blood flow and myocardial ischemia. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Braunwald’s Heart Disease. 9. Philadelphia: Elsevier; 2012. pp. 1049–1075.
    1. Beyer AM, Gutterman DD. Regulation of the human coronary microcirculation. J Mol Cell Cardiol. 2012;52:814–821. - PMC - PubMed
    1. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830–40. - PubMed
    1. Marzilli M, Merz CN, Boden WE, Bonow RO, Capozza PG, Chilian WM, DeMaria AN, Guarini G, Huqi A, Morrone D, Patel MR, Weintraub WS. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol. 2012;60:951–6. - PubMed
    1. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2–12. - PMC - PubMed